As per our earlier post, we are long $CVS from $28.56 based on our funds flow screen being overwhelming positive. The scale in is only 20% of the full position.The stock did not go lower to build a full position. Our trade management plan is to take the profits based
$CVS on earnings conference call this morning highlighted that $CVS expects $4.5Billion in PBM contract losses. Big customer losses are Chrysler, State of NJ, and Coventry. Further, the company expects $1.7Billion loss from Medicare Part D. There are significant implications here presenting themselves to long term investors. Clearly $MHS (Medco
Gold has spiked on the news that Reserve Bank of India bought 200 tons of gold from IMF. On October 26, 2009 we reduced gold allocation to zero in our Multi Asset Global Allocation Model. At that time, we knew that IMF was planning to sell 400 tons of gold.
On Oct 26,2009, we increased short allocation on our Equities Long Short Allocation Model. On Oct 26, we also reduced allocations to oil, gold, copper and emerging markets to zero. Yesterday, Dow Jones Average went up 200 points, oil went up, gold went up and emerging markets went up strongly.
www.thearorareport.com THE ARORA REPORT, Ltd. HOME OF THE UNIQUE ZYX CHANGE METHOD DEDICATED SOLELY TO PROFIT FROM CHANGE BY TRADING AND INVESTING VERIFIABLE PERFORMANCE RECORD Every closed trade since 2007, without exception, is included in the performance results. Number of winning positions: 162 Number of losing positions: 10 Average annualized
Per our earlier post, those following ZYX methodology, should have scaled in a 25% short sale on $GRMN around $39.20. Unfortunately price did not spike any higher to build a full position. Today, the competitor $Tom Tom reported much worse than expected earnings. In sympathy, $GRMN shares are down to
Since August 2009 this model has not performed . In this period, the market has been liquidity driven and the model clearly does not perform in such a markert. This model is being discarded. www.thearorareport.com THE ARORA REPORT, Ltd. HOME OF THE UNIQUE ZYX CHANGE METHOD DEDICATED SOLELY TO PROFIT
www.thearorareport.com THE ARORA REPORT, Ltd. HOME OF THE UNIQUE ZYX CHANGE METHOD DEDICATED SOLELY TO PROFIT FROM CHANGE BY TRADING AND INVESTING VERIFIABLE PERFORMANCE RECORD Every closed trade since 2007, without exception, is included in the performance results. Number of winning positions: 162 Number of losing positions: 10 Average annualized
www.thearorareport.com THE ARORA REPORT, Ltd. HOME OF THE UNIQUE ZYX CHANGE METHOD DEDICATED SOLELY TO PROFIT FROM CHANGE BY TRADING AND INVESTING VERIFIABLE PERFORMANCE RECORD Every closed trade since 2007, without exception, is included in the performance results. Number of winning positions: 162 Number of losing positions: 10 Average annualized
$HGSI stock is dipping in the premarket on the news that FDA says its anthrax drug may not work. Our analysis shows that the anthrax drug is not material to the future of this company. The stock price has risen due to the success of the Lupus drug. Any large